Compared with normal tissues, ANXA2 was upregulated in bladder urothelial carcinoma (BLCA), BRCA, CESC, CHOL, COAD, lymphoid neoplasm diffuse large B cell lymphoma (DLBC), ESCA, GBM, HNSC, KIRC, KIRP, brain lower grade glioma (LGG), LIHC, lung squamous cell carcinoma (LUSC), ovarian serous cystadenocarcinoma (OV), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), STAD, testicular germ cell tumor (TGCT), THCA, thymoma (THYM), UCEC and uterine carcinosarcoma (UCS). This evidence concerns the gene ANXA2 and glioblastoma.